China

Market Access

From roasts to billions: Navigating the biopharma investment...

At BIO-Europe, the session “From Roasts to Billions: Biopharma Investment Landscape” brought together leading voices from investment banking & VC.

News

Innovent gets OK for China's first home-grown IL-23p19 drug

Innovent has picked up approval in China for Pecondle, its anti-IL-23p19 antibody, as a treatment for moderate-to-severe plaque psoriasis.

News

Innovent files high-dose mazdutide for obesity in China

Innovent has filed a new high-strength version of its weight-loss drug mazdutide in China, aiming to help people with severe obesity.

R&D

Global pharmaceutical market projections through 2030

Global pharmaceutical market projections through 2030, with Norstella's Daniel Chancellor.

News

US vulnerable to China's API dominance, says report

China has such a dominant position in pharmaceutical ingredient production that there is a risk it will weaponise access, says a Congressional report.

News

Kelun gets world-first approval for TROP2 ADC

Kelun-Biotech has picked up another world-first approval for its TROP2-targeting ADC sac-TMT in non-small cell lung cancer.

From roasts to billions: Navigating the biopharma investment...

Innovent gets OK for China's first home-grown IL-23p19 drug

Innovent files high-dose mazdutide for obesity in China

Global pharmaceutical market projections through 2030

US vulnerable to China's API dominance, says report

Kelun gets world-first approval for TROP2 ADC

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

China

Editor's Picks